ArticleThe oncologist2025

Biweekly dosing of trifluridine-tipiracil reduces rates of myelosuppression while maintaining efficacy in patients with metastatic colorectal cancer.

Christopher Cann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.